Importantly, myocyte enhancer factor 2D (MEF2D), a member of the MEF2 family exhibiting functional effects on the progression of tumors including PC [21], might be a potential target of miR-451a according to bioinformatics prediction. Here, MEF2D is linked to pachyonychia congenita.